These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 15311725

  • 1. The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (part 1): an update of clinical experience in adults.
    Van Schayck CP, Donnell D.
    Int J Clin Pract; 2004 Jul; 58(7):678-88. PubMed ID: 15311725
    [Abstract] [Full Text] [Related]

  • 2. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
    Fireman P, Prenner BM, Vincken W, Demedts M, Mol SJ, Cohen RM.
    Ann Allergy Asthma Immunol; 2001 May; 86(5):557-65. PubMed ID: 11379808
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Equivalent efficacy and safety of a new HFA-134a formulation of BDP compared with the conventional CFC in adult asthmatics.
    Anderson PB, Langley SJ, Mooney P, Jones J, Addlestone R, Rossetti A, Cantini L.
    J Investig Allergol Clin Immunol; 2002 May; 12(2):107-13. PubMed ID: 12371526
    [Abstract] [Full Text] [Related]

  • 5. The efficacy and safety of QVAR (hydrofluoroalkane-beclometasone diproprionate extrafine aerosol) in asthma (Part 2): Clinical experience in children.
    van Schayck CP, Donnell D.
    Int J Clin Pract; 2004 Aug; 58(8):786-94. PubMed ID: 15372852
    [Abstract] [Full Text] [Related]

  • 6. Beclometasone dipropionate extrafine aerosol versus fluticasone propionate in children with asthma.
    van Aalderen WM, Price D, De Baets FM, Price J.
    Respir Med; 2007 Jul; 101(7):1585-93. PubMed ID: 17254760
    [Abstract] [Full Text] [Related]

  • 7. A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate.
    Fairfax A, Hall I, Spelman R.
    Ann Allergy Asthma Immunol; 2001 May; 86(5):575-82. PubMed ID: 11379810
    [Abstract] [Full Text] [Related]

  • 8. Hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol provides equivalent asthma control to chlorofluorocarbon beclomethasone dipropionate at approximately half the total daily dose.
    Davies RJ, Stampone P, O'Connor BJ.
    Respir Med; 1998 Jun; 92 Suppl A():23-31. PubMed ID: 9850360
    [Abstract] [Full Text] [Related]

  • 9. Clinical studies in asthmatics with a new non-extra fine HFA formulation of beclometasone dipropionate (BDP Modulite).
    Bousquet J, Cantini L.
    Respir Med; 2002 Aug; 96 Suppl D():S17-27. PubMed ID: 12201078
    [Abstract] [Full Text] [Related]

  • 10. Hydrofluoroalkane-134a beclomethasone dipropionate, 400 microg, is as effective as chlorofluorocarbon beclomethasone dipropionate, 800 microg, for the treatment of moderate asthma.
    Gross G, Thompson PJ, Chervinsky P, Vanden Burgt J.
    Chest; 1999 Feb; 115(2):343-51. PubMed ID: 10027430
    [Abstract] [Full Text] [Related]

  • 11. Usefulness of HFA-BDP for adult patients with bronchial asthma: randomized crossover study with fluticasone.
    Horiguchi T, Hayashi N, Ohira D, Torigoe H, Ito T, Hirose M, Sasaki Y, Shiga M, Miyazaki J, Kondo R, Tachikawa S.
    J Asthma; 2006 Sep; 43(7):509-12. PubMed ID: 16939990
    [Abstract] [Full Text] [Related]

  • 12. Switching from conventional to extrafine aerosol beclomethasone dipropionate therapy in children: a 6-month, open- label, randomized trial.
    Szefler SJ, Warner J, Staab D, Wahn U, Le Bourgeois M, van Essen-Zandvliet EE, Arora S, Pedersen S, Pediatric Study Group.
    J Allergy Clin Immunol; 2002 Jul; 110(1):45-50. PubMed ID: 12110818
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma.
    Vanden Burgt JA, Busse WW, Martin RJ, Szefler SJ, Donnell D.
    J Allergy Clin Immunol; 2000 Dec; 106(6):1209-26. PubMed ID: 11112914
    [Abstract] [Full Text] [Related]

  • 14. Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children.
    Pedersen S, Warner J, Wahn U, Staab D, Le Bourgeois M, Van Essen-Zandvliet E, Arora S, Szefler SJ, Pediatric Study Group.
    Pediatrics; 2002 Jun; 109(6):e92. PubMed ID: 12042586
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of beclomethasone dipropionate extrafine aerosol in childhood asthma: a 12-week, randomized, double-blind, placebo-controlled study.
    Nayak A, Lanier R, Weinstein S, Stampone P, Welch M.
    Chest; 2002 Dec; 122(6):1956-65. PubMed ID: 12475833
    [Abstract] [Full Text] [Related]

  • 16. Equivalence of asthma control with new CFC-free formulation HFA-134a beclomethasone dipropionate and CFC-beclomethasone dipropionate.
    Dahl R, Ringdal N, Ward SM, Stampone P, Donnell D.
    Br J Clin Pract; 1997 Dec; 51(1):11-5. PubMed ID: 9158265
    [Abstract] [Full Text] [Related]

  • 17. Health-related quality of life in moderate asthma: 400 microg hydrofluoroalkane beclomethasone dipropionate vs 800 microg chlorofluorocarbon beclomethasone dipropionate. The Study Group.
    Juniper EF, Buist AS.
    Chest; 1999 Nov; 116(5):1297-303. PubMed ID: 10559091
    [Abstract] [Full Text] [Related]

  • 18. Stepping-across controlled asthmatic patients to extrafine beclometasone/formoterol combination.
    Barnes N, van Noord JA, Brindicci C, Lindemann L, Varoli G, Perpiña M, Guastalla D, Casula D, Patel S, Chanez P, FACTO (Foster® As Complete Treatment Option) Study Group.
    Pulm Pharmacol Ther; 2013 Oct; 26(5):555-61. PubMed ID: 23524015
    [Abstract] [Full Text] [Related]

  • 19. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
    Fowler SJ, Currie GP, Lipworth BJ.
    J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
    [Abstract] [Full Text] [Related]

  • 20. Extrafine beclomethasone dipropionate breath-actuated inhaler (400 micrograms/day) versus budesonide dry powder inhaler (800 micrograms/day) in asthma.
    Reichel W, Dahl R, Ringdal N, Zetterstrom O, van den Elshout FJ, Laitinen LA.
    Int J Clin Pract; 2001 Mar; 55(2):100-6. PubMed ID: 11321849
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.